Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer.

Saved in:
Bibliographic Details
Title: Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer.
Authors: Wang, Ji1 (AUTHOR), Wang, Xinyang1 (AUTHOR), Chen, Rui1 (AUTHOR), Liang, Mengdi1 (AUTHOR), Li, Minghui1 (AUTHOR), Ma, Ge1 (AUTHOR), Xia, Tiansong1,2 (AUTHOR) xiatsswms@163.com, Wang, Shui1,2 (AUTHOR) shwang@njmu.edu.cn
Source: International Journal of Clinical Oncology. May2022, Vol. 27 Issue 5, p889-898. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13419625
DOI:10.1007/s10147-022-02125-9